Dana-Farber Cancer Institute H-1B Wage Premium Over Prevailing Wage
Across 640 certified H-1B filings from Dana-Farber Cancer Institute (FY2021–2026), the offered wage runs a median 34.8% above the DOL prevailing wage, the legally required floor for that role, level, and location.
What This Measures
Every Labor Condition Application states a DOL "prevailing wage", the legal minimum an employer must pay for that occupation, skill level, and worksite location. This page compares Dana-Farber Cancer Institute's actual offered wage against that floor, averaged across its certified filings. A high premium means offers well above the legal minimum; a premium near 0% means offers are filed at, or close to, the floor. It is not a measure of job security or employer quality by itself, but it is a real, directly comparable pay signal across employers.
Wage Premium by Role at Dana-Farber Cancer Institute
| Occupation | Filings | Avg. Premium |
|---|---|---|
| Molecular and Cellular Biologists | 299 | 38.2% |
| Bioinformatics Scientists | 98 | 53.6% |
| Physicians, All Other | 45 | 13.8% |
| Statisticians | 36 | 27.7% |
| Biochemists and Biophysicists | 35 | 46.2% |
Related H-1B Data
Sponsor Intel Pro
🔍 Know your H1B sponsors inside out
Research 100K+ H1B sponsors with approval rates, salary data, and transfer success rates.
- ✓ 100,000+ verified employers
- ✓ Real LCA approval rates
- ✓ Salary & benefits breakdown
- ✓ Transfer difficulty scoring
H1B Visa Jobs Research Team
Computed from US Department of Labor LCA disclosure files (FY2021–2026) for Dana-Farber Cancer Institute, comparing offered wage to DOL prevailing wage, filtered to certified petitions with annual wages between $30K and $1M and a valid prevailing-wage comparison. Prevailing-wage units outside Year/Hour are excluded rather than estimated.